Sequential high-dose chemotherapy protocol for relapsed poor prognosis germ cell tumors combining two mobilization and cytoreductive treatments followed by three high-dose chemotherapy regimens supported by autologous stem cell transplantation. Results of the phase II multicentric TAXIF trial
2005
Background: High-dose chemotherapy (HD-CT) is able to circumvent platinum resistance of resistant/refractory germ-cell tumors (GCTs), but expectancy of cure remains low. New strategies are needed with new drugs and a sequential approach. Materials and methods: Patients with relapsed poor-prognosis GCTs were scheduled to receive two cycles combining epirubicin and paclitaxel (Taxol) followed by three consecutive HD-CT supported by stem cell transplantation [one course combining cyclophosphamide, 3 g/m 2 + thiotepa, 400 mg/m 2 , followed by two ICE regimens (ifosfamide, 10 g/m 2 , carboplatin, AUC 20, etoposide, 1500 mg/m 2 )].
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
42
References
49
Citations
NaN
KQI